4-bromo-1-(3-hydroxypropyl)-1H-pyrazole-3-carbonitrile → 3-amino-6-[3-cyano-1-(3-hydroxypropyl)-1H-pyrazol-4-yl]-N-methylpyridine-2-carboxamide
Reaction equation
NC1C=CC(C2C=NN(CCCO)C=2)=CC=1C(N(CC)CC)=O.[NH2:24][C:25]1[C:26]([C:40]([NH:42][CH3:43])=[O:41])=[N:27][C:28](B2OC(C)(C)C(C)(C)O2)=[CH:29][CH:30]=1.Br[C:45]1[C:46]([C:54]#[N:55])=[N:47][N:48]([CH2:50][CH2:51][CH2:52][OH:53])[CH:49]=1>>[NH2:24][C:25]1[C:26]([C:40]([NH:42][CH3:43])=[O:41])=[N:27][C:28]([C:45]2[C:46]([C:54]#[N:55])=[N:47][N:48]([CH2:50][CH2:51][CH2:52][OH:53])[CH:49]=2)=[CH:29][CH:30]=1Participants
4
Reactant 3
Product 1
Procedure
Prepared analogously to Compound 3C using 3-amino-N-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxamide (Compound 48D, 657 mg, 2.37 mmol) and 4-bromo-1-(3-hydroxypropyl)-1H-pyrazole-3-carbonitrile (Compound 52E, 600 mg, 2.61 mmol) to afford 164 mg of the title compound (23%). 1H NMR (400 MHz, CD3OD) δ 8.29 (s, 1H), 7.57 (d, J=8.6 Hz, 1H), 7.21 (d, J=8.6 Hz, 1H), 4.35 (t, J=6.8 Hz, 2H), 3.57 (t, J=6.1 Hz, 2H), 2.94 (s, 3H), 2.11 (t, J=6.1 Hz, 2H). MS (ESI): m/z=301.24 [M+H]+. UPLC: tR=0.79 min (UPLC-TOF: polar—2 min).
Sources & evidence
- ORD record
- ord-df5da4f499c5491baa498fd0c29169a6
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09133224B2
Reaction notes
Loading…